PHOENIX MEDICAL GROUP
PHOENIX MEDICAL GROUP, 4 THE WATERFRONT, WORTHING, WEST SUSSEX
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8 | 13 | 61.5% | |
| HF 4 | 2011 | 12 | 16 | 75.0% | |
| HF 4 | 2012 | 11 | 14 | 78.6% | |
| HF 4 | 2013 | 15 | 17 | 88.2% | |
| HF004 | 2014 | 2 | 2 | 100.0% | |
| HF004 | 2015 | 3 | 3 | 100.0% | |
| HF004 | 2016 | 4 | 4 | 100.0% | |
| HF004 | 2017 | 4 | 4 | 100.0% | |
| HF004 | 2018 | 19 | 25 | 76.0% | |
| HF004 | 2019 | 22 | 27 | 81.5% | |
| HF004 | 2020 | 18 | 25 | 72.0% |
